1. Role of skin autofluorescence in managing renal and cardiac diseases in outpatient dermatology
- Author
-
Farshid Etaee, Tarek Naguib, Mohamad Goldust, Steven Daveluy, and Howard Maibach
- Subjects
Glycation End Products, Advanced ,end-stage renal disease ,Kidney Disease ,Heart Diseases ,advanced glycation end products ,Clinical Sciences ,Renal and urogenital ,Glycation End Products ,Bioengineering ,Dermatology ,Cardiovascular ,Atherosclerosis ,kidney failure ,skin autofluorescence ,Good Health and Well Being ,Outpatients ,Humans ,Advanced ,Zero Hunger ,Renal Insufficiency ,Chronic ,Renal Insufficiency, Chronic ,Biomarkers ,Skin - Abstract
IntroductionThe accumulation of tissue-advanced glycation end products in skin results from complex and consecutive reactions and can be measured by skin autofluorescence (SAF) reader devices. This overview discusses studies evaluating the utilization of SAF in screening renal and cardiac disease.Materials and methodsLiterature search was performed using Google Scholar, PubMed, Springer, Ovid, and ScienceDirect.ResultsSAF was an independent predictor of progression of chronic kidney disease (CKD) and was elevated in subjects on hemodialysis and peritoneal dialysis. Furthermore, SAF was significantly associated with cardiovascular events, cardiovascular mortality, and all-cause mortality in CKD patients. Other studies revealed a correlation between SAF and arterial stiffness, vascular damage, and subclinical atherosclerosis. A vegetarian diet was associated with lower SAF levels, whereas malnutrition was correlated with higher levels and increased mortality.ConclusionsSAF measurement may be useful in managing renal and cardiac disease. Future studies are needed to clarify the specific role of SAF in the management of CKD and its noninvasive office utilization to identify comorbidities in inflammatory diseases, such as psoriasis.
- Published
- 2022